Form 4: BeiGene CEO John Oyler Sells Shares Under 10b5-1 Trading Plan
SEC Form 4 Filing
BeiGene's CEO, John Oyler, executed multiple sales of American Depositary Shares (ADS) between April 9 and April 11, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- John Oyler, CEO of BeiGene, Ltd., sold American Depositary Shares (ADS) of the company between April 9 and April 11, 2024.
- The sales were executed under a Rule 10b5-1 trading plan adopted on December 12, 2023.
- The transactions involved multiple sales at varying prices ranging from approximately $145.39 to $154.83 per ADS.
- Oyler sold a total of 542 ADS on April 9, 2024, at an average price of $152.2839.
- On April 9, 2024, Oyler sold 2,734 ADS at an average price of $153.472.
- On April 9, 2024, Oyler sold 7,924 ADS at an average price of $154.2084.
- On April 10, 2024, Oyler sold 11,514 ADS at an average price of $148.3962.
- On April 10, 2024, Oyler sold 12,501 ADS at an average price of $149.1539.
- On April 10, 2024, Oyler sold 2,641 ADS at an average price of $149.7931.
- On April 10, 2024, Oyler sold 60 ADS at an average price of $150.85.
- On April 11, 2024, Oyler sold 5,008 ADS at an average price of $146.088.
- On April 11, 2024, Oyler sold 4,265 ADS at an average price of $146.816.
- On April 11, 2024, Oyler sold 2,811 ADS at an average price of $147.7432.
- Following these transactions, Oyler directly owns 1,321,554 ordinary shares.
- Oyler also indirectly owns a significant number of ordinary shares through various trusts and entities, for which he disclaims beneficial ownership.
Sentiment
Score: 5
Explanation: The document simply reports share sales by the CEO under a pre-existing trading plan. It's a neutral event, neither particularly positive nor negative.
Industry Context
Sales by company executives are a common occurrence and are often pre-planned to avoid accusations of insider trading. The use of a 10b5-1 trading plan allows insiders to sell shares at predetermined times and prices.
Stakeholder Impact
- The share sales could have a minor negative impact on shareholder sentiment, although the existence of a pre-arranged trading plan mitigates this concern.
Key Dates
| Date | Description |
|---|---|
| 12/12/2023 | Date of adoption of the Rule 10b5-1 trading plan. |
| 04/09/2024 | Date of first reported transaction. |
| 04/10/2024 | Date of subsequent reported transactions. |
| 04/11/2024 | Date of last reported transaction. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.